NCT03878238 is a NA clinical trial of Probiotic Bths-003 in Acne, sponsored by Bionou Research, S.L..

Who is sponsoring NCT03878238?

NCT03878238 is sponsored by Bionou Research, S.L..

What drugs are being tested in NCT03878238?

Interventions in NCT03878238: Probiotic Bths-003, Placebo.

What condition does NCT03878238 study?

NCT03878238 studies Acne, Acne Vulgaris.

Is NCT03878238 still recruiting?

NCT03878238 is currently completed. Last updated 10 July 2019.

Last reviewed 2019-07-10 · How we verify

NCT03878238

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Pilot Study to Evaluate the Effect of a Probiotic Mixture in Acne

Completed NA Last updated 10 July 2019

What this trial tests

NA trial testing Probiotic Bths-003 in Acne in 25 participants. Completed in 29 May 2019.

Timeline

11 July 2018

Primary endpoint
15 April 2019

29 May 2019

Quick facts

Lead sponsor	Bionou Research, S.L.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	25
Start date	11 July 2018
Primary completion	15 April 2019
Estimated completion	29 May 2019
Sites	1 location across Spain

Drugs / interventions tested

Probiotic Bths-003
Placebo

Conditions studied

Acne — all drugs for Acne →
Acne Vulgaris — all drugs for Acne Vulgaris →

Sponsor

Bionou Research, S.L.

Who can join

Adults 12 to 30, any sex, with Acne or Acne Vulgaris. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A 12-week randomized, double-blind, placebo-controlled pilot study to evaluate the effect of a probiotic blend in the treatment and clinical and subjective evolution of acne vulgaris in adolescent and adult patients between 12 and 30 years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acne

Currently open trials in the same condition.

NCT07366229 — Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne · Phase 2 · recruiting
NCT07013747 — Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne · Phase 1, PHASE2 · recruiting
NCT06989840 — Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne · Phase 1 · recruiting
NCT07368764 — The Suitability of Tience® for Treating Acne Scars · NA · recruiting
NCT06909344 — 577-nm Diode Laser in the Treatment of Non -Inflammatory Acne · NA · recruiting

Other Bionou Research, S.L. trials

Trials by the same sponsor.

NCT05815511 — Clinical Trial to Evaluate the Effect of a Probiotic Mixture on the Rosacea Evolution · NA · completed
NCT04570319 — Clinical Trial to Evaluate the Effect of a Probiotic in Acne · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03878238 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bionou Research, S.L.
Last refreshed: 10 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03878238.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing